Leadership & Management
Women in Leadership Series – Interview with Leanne Elich

Leadership takes courage and resilience. Health Industry Hub Founder, Rozalina Sarkezians, shares insights from Pharma, MedTech and Biotech’s diverse female leaders on the sometimes complex challenges faced by women on the path to senior leadership.
Leanne Elich’s intriguing background, from a clinical oncologist to the MedTech industry and more recently to a consulting role, makes her the perfect candidate to discuss the following:
- How do you respond to Workplace Gender Equality Agency (WGEA)’s recent data on the gender pay gap in Australia?
- What are key challenges that you have faced over the years as a female leader? How did you find the inspiration to overcome these?
- What is the one key insight about leadership that you wish a mentor had told you about years ago?
- How would you like to see ‘women in leadership’ evolve in the post-COVID era?
Interview
About
As one of Australasia’s successful Medical Technology Business Leaders, Leanne Elich is a passionate Oncology Advocate and Global Healthcare Specialist with over 25 years experience in both clinical and corporate environments with executive leadership.
Leanne began her career immediately after graduating from the University of Sydney working as a medical oncologist at Prince of Wales and Liverpool Hospitals in Sydney.
With a desire to help patients on a larger scale and make a significant impact within the healthcare industry, she transitioned into oncology and medical business working for several high profile companies specialising in the latest technology. There she was able to continue her passion of oncology and medical research together with business development, commercialisation and advocacy, expanding her network and business relationships locally and internationally.
Leanne is a graduate of the Australian Institute of Company Directors (GAICD). She is an Honorary Clinical Fellow and a University guest lecturer in both Australia and New Zealand.
Leanne is a graduate of both Harvard Business School and Harvard Medical School and is an International Keynote Speaker, Writer and Women in Leadership advisor.
News & Trends - MedTech & Diagnostics

Government’s claim of progress in genomics falls flat while it fails to uphold the fundamental rights of Aussies
The government has unveiled Cancer Australia’s National Framework for Genomics in Cancer Control, a strategic plan designed to guide healthcare […]
MoreNews & Trends - Pharmaceuticals

Healthcare sector’s political donations: What to expect ahead of the federal election
Ahead of the upcoming federal election, attention turns to the financial contributions to major political parties. The Australian Electoral Commission’s […]
MoreNews & Trends - Pharmaceuticals

‘Underinvestment in gynae cancer has left critical gaps,’ says ANZGOG Chair
Ovarian cancer is the deadliest women’s cancer, with the latest statistics revealing a five-year survival rate of just 49%. Alarmingly, […]
MoreNews & Trends - MedTech & Diagnostics

Labor’s one-off funding a band aid for public hospitals while private sector left in limbo
The Federal Government has committed a one-off funding boost of $1.7 billion to public hospitals under a one-year extension to […]
More